These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 32212186)

  • 1. Paradoxical scintigraphy bone scan findings with malignancy-associated extreme hypercalcemia.
    Peters N; Slattery L; Crowley C; Bennett MW; Barry J; O'Reilly S
    Breast J; 2020 Jul; 26(7):1372-1374. PubMed ID: 32212186
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Uncommon cause of hypercalcaemia in metastatic breast carcinoma.
    Barnabas R; Singh A; Paul MJ; Paul TV
    BMJ Case Rep; 2018 Feb; 2018():. PubMed ID: 29472426
    [No Abstract]   [Full Text] [Related]  

  • 3. [Bone scintigraphy in patients with malignancy associated with hypercalcemia].
    Fukunaga M; Otsuka N; Sone T; Nagai K; Ono S; Muranaka A; Furukawa T; Yanagimoto S; Tomomitsu T; Morita R
    Kaku Igaku; 1986 May; 23(5):495-8. PubMed ID: 3735789
    [No Abstract]   [Full Text] [Related]  

  • 4. Hypercalcaemia and metastatic bone disease: is there a causal link?
    Ralston S; Fogelman I; Gardner MD; Boyle IT
    Lancet; 1982 Oct; 2(8304):903-5. PubMed ID: 6126753
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Multiple extra-osseous accumulation of 99mTc-phosphorous compounds bone scintigraphy in small cell lung cancer associated with hypercalcemia].
    Otsuka N; Fukunaga M; Morita K; Ono S; Ohga R; Tsukayama C; Okimoto N; Soejima R
    Rinsho Hoshasen; 1990 Oct; 35(11):1459-62. PubMed ID: 2177511
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intravenous aminohydroxypropylidene bisphosphonate does not modify 99mTc-hydroxymethylene bisphosphonate bone scintigraphy. A prospective study.
    Macro M; Bouvard G; Le Gangneux E; Colin T; Loyau G
    Rev Rhum Engl Ed; 1995 Feb; 62(2):99-104. PubMed ID: 7600079
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Relative contribution of humoral and metastatic factors to the pathogenesis of hypercalcaemia in malignancy.
    Ralston SH; Fogelman I; Gardiner MD; Boyle IT
    Br Med J (Clin Res Ed); 1984 May; 288(6428):1405-8. PubMed ID: 6426577
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Extensive visceral calcification demonstrated on Tc-99m MDP bone scan in patient with sphenoidal sinus carcinoma and hypercalcaemia of malignancy: a bad prognostic sign.
    Usmani S; Khan HA; Abu Huda F; Al Nafisi N; Al Mohannadi S
    Gulf J Oncolog; 2011 Jan; (9):61-4. PubMed ID: 21177211
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Primary hyperparathyroidism as a cause of hypercalcemia in a patient with breast cancer].
    Zajícková K
    Cas Lek Cesk; 2010; 149(11):546-8. PubMed ID: 21391355
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Correlation between bone scintigraphy and tumor markers in patients with breast carcinoma.
    Begić A; Kucukalić-Selimović E; Obralić N; Durić O; Lacević N; Skopljak A
    Bosn J Basic Med Sci; 2006 Feb; 6(1):75-7. PubMed ID: 16533185
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Non-osseous bone scan abnormalities in multiple myeloma associated with hypercalcemia.
    Eagel BA; Stier SA; Wakem C
    Clin Nucl Med; 1988 Dec; 13(12):869-73. PubMed ID: 3246115
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bone metastases and hypercalcaemia from cutaneous squamous cell carcinoma.
    Vlachostergios PJ; Balmiki RL
    BMJ Case Rep; 2014 Jun; 2014():. PubMed ID: 24913085
    [No Abstract]   [Full Text] [Related]  

  • 13. Hypercalcemia induced by metastatic bone cancer in a patient with chronic renal failure.
    Kajiyama H; Kuroiwa T; Ueki K; Kanai H; Maezawa A; Yano S; Nojima Y; Naruse T
    Clin Nephrol; 2000 Oct; 54(4):347-50. PubMed ID: 11076112
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 99mTc depreotide scan compared with 99mTc-MDP bone scintigraphy for the detection of bone metastases and prediction of response to hormonal treatment in patients with breast cancer.
    Van Den Bossche B; D'haeninck E; De Winter F; Van Belle S; Dierckx RA; Van De Wiele C
    Nucl Med Commun; 2004 Aug; 25(8):787-92. PubMed ID: 15266172
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mechanism of malignant hypercalcaemia in carcinoma of the breast.
    Percival RC; Yates AJ; Gray RE; Galloway J; Rogers K; Neal FE; Kanis JA
    Br Med J (Clin Res Ed); 1985 Sep; 291(6498):776-9. PubMed ID: 3929936
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Two cases of malignancy-associated hypercalcemia from bone metastases of breast cancer successfully treated with combination therapy using pamidronate and calcitonin].
    Kusama M; Kaise H; Nakayama S; Ota D; Aoki T; Koyanagi Y; Matsunaga T; Nakamura Y
    Gan To Kagaku Ryoho; 2000 May; 27(5):763-6. PubMed ID: 10832449
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fatal irreversible hypercalcaemia in breast cancer.
    Cornbleet M; Bondy PK; Powles TJ
    Br Med J; 1977 Jan; 1(6054):145. PubMed ID: 832039
    [No Abstract]   [Full Text] [Related]  

  • 18. Poorly differentiated lymphocytic lymphoma with ectopic parathormone production: visulization of metastatic calcification by bone scan.
    Williamson BR; Carey RM; Innes DJ; Teates CD; Bray ST; Lees RF; Sturgill BC
    Clin Nucl Med; 1978 Oct; 3(10):382-4. PubMed ID: 215369
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The treatment of hypercalcemia associated with metastases to bone from primary breast cancer.
    Ariel IM; Kempner R
    Bull Hosp Jt Dis Orthop Inst; 1988; 48(1):82-7. PubMed ID: 2840153
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The value of bone marrow scintigraphy in patients with recurrent breast cancer].
    Langer SW; Kamby C; Thomsen HS; Sørensen T; Hvid-Jacobsen K; Dombernowsky P; Nielsen SL
    Ugeskr Laeger; 1993 Mar; 155(11):778-82. PubMed ID: 8460428
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.